Precigen (PGEN) Accumulated Expenses (2012 - 2026)
Precigen (PGEN) reported Accumulated Expenses of $4.6 million for Q1 2026, down 52.65% year-over-year from $9.6 million in Q1 2025, and down 55.33% quarter-over-quarter from $10.2 million in Q4 2025.
Precigen (PGEN) Accumulated Expenses (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Accumulated Expenses data on file, last reported at $4.6 million in Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $4.6 million, down 52.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.6 million (down 52.65% YoY), and the FY2025 annual result was $10.2 million, up 21.17% from the prior year.
- Accumulated Expenses retreated to $4.6 million in Q1 2026 per PGEN's latest filing, from $10.2 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $10.2 million in Q4 2025 and troughed at $4.6 million in Q1 2026.
- A 5-year average of $7.0 million and a median of $6.6 million in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2026: Accumulated Expenses surged 100.89% in 2024, then slumped 52.65% in 2026.
- A 5-year view of Accumulated Expenses shows it stood at $6.4 million in 2022, then gained by 29.37% to $8.2 million in 2023, then advanced by 2.02% to $8.4 million in 2024, then advanced by 21.17% to $10.2 million in 2025, then tumbled by 55.33% to $4.6 million in 2026.
- Business Quant data shows PGEN's Accumulated Expenses at $4.6 million in Q1 2026, $10.2 million in Q4 2025, and $10.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Precigen | 1.32 Bn | 1.32 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.56 Mn |
| Dec 31, 2025 | 10.20 Mn |
| Sep 30, 2025 | 10.17 Mn |
| Jun 30, 2025 | 5.20 Mn |
| Mar 31, 2025 | 9.62 Mn |
| Dec 31, 2024 | 8.42 Mn |
| Sep 30, 2024 | 6.61 Mn |
| Jun 30, 2024 | 6.68 Mn |
| Mar 31, 2024 | 9.96 Mn |
| Dec 31, 2023 | 8.25 Mn |
| Sep 30, 2023 | 6.62 Mn |
| Jun 30, 2023 | 4.82 Mn |
| Mar 31, 2023 | 4.96 Mn |
| Dec 31, 2022 | 6.38 Mn |
| Sep 30, 2022 | 5.79 Mn |
| Jun 30, 2022 | 4.86 Mn |
| Mar 31, 2022 | 6.05 Mn |
| Dec 31, 2021 | 7.86 Mn |
| Sep 30, 2021 | 8.08 Mn |
| Jun 30, 2021 | 7.77 Mn |